FDA increasingly approves drugs without conclusive proof they work
As pharma companies underwrite three-fourths of the FDA’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits.
U.S. approves marijuana-based drug for seizures
The Food and Drug Administration approved the medication from GW Pharmaceuticals on Monday to treat two rare forms of childhood epilepsy. It's a milestone that could spur more research into a drug that remains illegal under federal law.
White House proposes a reduction of the FDA’s mission
The idea of changing a key mission of the FDA comes amid a turf war between the FDA and the USDA over the regulation of genetically engineered animals.
FDA says liquid nicotine products that resemble candy, juice boxes are a danger to children
The Food and Drug Administration issued more than a dozen warnings over the illegal packaging practice, saying it can lead to poisoning if children mistakenly drink the liquids, which are intended for use with e-cigarettes and vaping devices.
The Food and Drug Administration posted its review Tuesday of the experimental medication ahead of a public meeting later this week.
Under one scenario, the FDA estimates reducing nicotine could help the U.S. smoking rate could fall as low as 1.4 percent by 2060, down from the 15 percent of adults who smoke now.
A government shutdown of the FDA, CDC and NIH will likely have widespread and long-lasting consequences for public health.
A wearable device claiming to block the pain of opioid withdrawal has been cleared by the Food and Drug Administration under a new expedited review process.
New findings highlight just how hard it has been for the FDA to keep potentially unsafe supplement ingredients off the market.
